sur ABIVAX (EPA:ABVX)
Crossing of threshold at ABIVAX: statement from Sofinnova
On February 17, 2025, Sofinnova Partners informed ABIVAX of a crossing of the voting rights threshold. As of July 6, 2024, Sofinnova held 8.37% of the capital and 10.27% of the voting rights. The increase is due in particular to the allocation of double voting rights.
Currently, Sofinnova owns 8.31% of the capital and 10.98% of the voting rights of the company. The institute does not plan to purchase more shares or take control of ABIVAX. The aim is to continue supporting ABIVAX in its efforts to develop its products and seek financing.
Sofinnova specifies that it is not a party to agreements mentioned in Article L. 233-9 of the French Commercial Code, nor does it plan any significant structural changes within ABIVAX.
R. E.
Copyright © 2025 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de ABIVAX